Jerome J Schentag, Pharm D

Similar documents
Introduction to Pharmacokinetics and Pharmacodynamics

Antimicrobial Pharmacodynamics

Contribution of pharmacokinetic and pharmacodynamic parameters of antibiotics in the treatment of resistant bacterial infections

The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens

CHSPSC, LLC Antimicrobial Stewardship Education Series

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

CF WELL Pharmacology: Microbiology & Antibiotics

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases

DETERMINING CORRECT DOSING REGIMENS OF ANTIBIOTICS BASED ON THE THEIR BACTERICIDAL ACTIVITY*

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES

Pharmacokinetic & Pharmadynamic of Once Daily Aminoglycosides (ODA) and their Monitoring. Janis Chan Pharmacist, UCH 2008

Appropriate antimicrobial therapy in HAP: What does this mean?

Antimicrobial therapy in critical care

What Have We Learned from Pharmacokinetic and Pharmacodynamic Theories?

Curricular Components for Infectious Diseases EPA

DETERMINANTS OF TARGET NON- ATTAINMENT IN CRITICALLY ILL PATIENTS RECEIVING β-lactams

Pharmacokinetics and Pharmacodynamics of Antimicrobials in the Critically Ill Patient

Clinical Practice Standard

Antibiotic Stewardship in the LTC Setting

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Building a Better Mousetrap for Nosocomial Drug-resistant Bacteria: use of available resources to optimize the antimicrobial strategy

Introduction to Antimicrobial Therapy

Effective 9/25/2018. Contact for previous versions.

Pharmacist-Driven ASP. Jessica Holt, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Coordinator October 24 th, 2013

Standing Orders for the Treatment of Outpatient Peritonitis

Antibiotic Kinetic and Dynamic Attributes for Community-Acquired Respiratory Tract Infections

Systemic Antimicrobial Prophylaxis Issues

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

The Role of the Staff Pharmacist in Antimicrobial Stewardship

Standing Orders for the Treatment of Outpatient Peritonitis

Antibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents

Antimicrobial utilization: Capital Health Region, Alberta

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1

Bacterial Resistance of Respiratory Pathogens. John C. Rotschafer, Pharm.D. University of Minnesota

Patients. Excludes paediatrics, neonates.

Sustaining an Antimicrobial Stewardship

Percent Time Above MIC ( T MIC)

Pharmaceutical Form Ciprofloxacin 2 mg/ml Solution for infusion. Applicant Name Strength. Ciprofloxacin Nycomed. Ciprofloxacin Nycomed

Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S.

Cost high. acceptable. worst. best. acceptable. Cost low

Antibiotic Updates: Part II

Antibiotic Usage Guidelines in Hospital

Antibiotic Stewardship Program (ASP) CHRISTUS SETX

Proceedings of the 13th International Congress of the World Equine Veterinary Association WEVA

Evaluating the Role of MRSA Nasal Swabs

General Infectious Disease Concepts/Resources

Lack of Change in Susceptibility of Pseudomonas aeruginosa in a Pediatric Hospital Despite Marked Changes in Antibiotic Utilization

Systematic Review of Clinical PK-PD Studies of Antibacterials. Alex McAleenan Julian Higgins Alasdair MacGowan William Hope Johan Mouton

Introduction to Antimicrobial Therapy

Duke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients

OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient

Appropriate Antimicrobial Therapy for Treatment of

Considerations in antimicrobial prescribing Perspective: drug resistance

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Antibiotic stewardship in long term care

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

January 2014 Vol. 34 No. 1

ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies

Drive More Efficient Clinical Action by Streamlining the Interpretation of Test Results

Antimicrobial Pharmacokinetics/dynamics Bedside Applications in the Critically Ill

Sepsis is the most common cause of death in

Alasdair P. MacGowan*, Mandy Wootton and H. Alan Holt

Developed by Kathy Wonderly RN, MSEd,CPHQ Developed: October 2009 Most recently updated: December 2014

Impact of Antimicrobial Stewardship Program

SHC Surgical Antimicrobial Prophylaxis Guidelines

Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice?

CARBAPENEM RESISTANT ENTEROBACTERIACEAE (KPC CRE)

Rational use of antibiotics

Use of Pharmacokinetics and Pharmacodynamics to Optimize Antimicrobial Treatment of Pseudomonas aeruginosa Infections

Pathogens and Antibiotic Sensitivities in Post- Phacoemulsification Endophthalmitis, Kaiser Permanente, California,

Comparative studies on pulse and continuous oral norfloxacin treatment in broilers and turkeys. Géza Sárközy

Understanding the Hospital Antibiogram

Choosing the Ideal Antibiotic Therapy and the Role of the Newer Fluoroquinolones in Respiratory Tract Infections

Jump Starting Antimicrobial Stewardship

Why we perform susceptibility testing

Introduction to Antimicrobial Therapy

Antibiotic Pharmacokinetics and Pharmacodynamics for Laboratory Professionals

MEASURING ANTIBIOTIC USE IN LTCFS

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REVISED GUIDELINE ON THE SPC FOR ANTIMICROBIAL PRODUCTS

Becker s Hospital Review

PK/PD to fight resistance

Antimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD

Creating an EHR-based Antimicrobial Stewardship Program Session #257, March 8, 2018 David Ratto M.D., Chief Medical Information Officer, Methodist

Journal of Antimicrobial Chemotherapy Advance Access published August 26, 2006

MDR Acinetobacter baumannii. Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta

Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis

Amikacin monotherapy for pan-resistant Pseudomonas aeruginosa sepsis

Int.J.Curr.Microbiol.App.Sci (2017) 6(3):

Antimicrobial Stewardship

CLINICAL USE OF AMINOGLYCOSIDES AND FLUOROQUINOLONES

Understand the application of Antibiotic Stewardship regulations in LTC. Understand past barriers to antibiotic management concepts

Other Beta - lactam Antibiotics

* gender factor (male=1, female=0.85)

ESCMID Online Lecture Library. by author

Using Data to Track Antibiotic Use and Outcomes

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose

ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae

Transcription:

Clinical Pharmacy and Optimization of Antibiotic Usage: How to Use what you have Learned in Pharmacokinetics and Pharmacodynamics of Antibiotics Jerome J Schentag, Pharm D Presented at UCL on Thursday February 28th 1

Systems Approach to Antibiotics Value: Making sure every patient receives excellent care, every time.. The Theoretical studies provide the means to do this We will talk about both theories and about putting them to work 2

Antibiotic serum concentration C max (peak) AUC AUIC= Half life AUC24 MIC MIC Time above MIC C min (trough) Time 3

Antibiotic PK and PD attributes For antimicrobial effect: - C max /MIC ratio should be > 8 to 10 - AUIC should be > 125 (For rapid killing AUIC > 250) To minimize resistance development: - AUIC should be >100 4

Antibiotics for Study in LRTI Concentration Dependent Actions Fluoroquinolones Aminoglycosides Concentration Independent Actions Beta Lactams Vancomycin 5

Tobramycin serum concentration 6 2 1 0.5 C max (peak) 0 Peak:MIC=3, AUIC=27 Peak:MIC=6, AUIC=54 Peak:MIC=12, AUIC=108 Tobramycin: 2 peaks of 6.0 in 24 hours AUC24 =54 Time, hours 12 6

Aminoglycosides Low AUIC with typical dosing and levels breakpoint MIC is 0.25 mcg/ml for AUIC of 125 We say their activity is decreased with the infection site ph below 6.0 at urine sites due to cations with decreased PO 2 due to binding at the infection site Combination Therapy is necessary in most situations, because of a low AUIC

Antibiotic Combinations Compound AUC 24 MIC P.aerug AUIC 24 Tobramycin 54 1.0 54 Ceftazidime 400 2.0 200 Total (Tob+Ceftaz) 254 8

Ceftazidime serum concentration 100 10 2 21 1.5 C max (peak) AUIC=40 Peak:MIC=50, AUIC=200 Peak:MIC=100, AUIC=400 Ceftazidime 1000 mg BID: Two SS pks of 100 in 24 hours AUC24 =400; AUIC=AUC24 /MIC MIC 0 Time, hours 66 12 9

% remaining Culture positive 100 75 50 25 0 = Ceftazidime AUIC < 125 = Ceftazidime AUIC > 125 = Cefmenoxime AUIC < 125 = Cefmenoxime AUIC > 125 0 7 14 21 Time, Days of Treatment

Do Aminoglycosides protect against Resistance? Activity against the pre-existing sub-population that is resistant to the concomitant beta lactam? If so, then AUIC drives the action and additivity laws are served Protection only when the aminoglycosides contribute enough to bring total AUIC above 125. 11

Consequences of Under-dosing with Antibiotics Failure to Eradicate Long Eradication Time Resistance develops when AUIC is below 100 12

Thomas JK, Antimicrobial Agents Chemother. 1998. Probability of remaining susceptible 100 75 50 25 0 AUIC vs Resistance AUIC>101 AUIC<100 0 5 10 15 20 Days from initiation of Therapy 13

Linkage between dosing and Antibiotic Resistance Marginal Organisms (MIC at the breakpoint) are the first organisms to express resistance Emergence by selective pressure occurs when dosing is lowered below MIC. Example: Ofloxacin resistant Pseudomonas aeruginosa Individual patients with foreign bodies and low doses are reservoirs for these resistant pathogens, once these conditions occur 14

Clinical Approaches Dose to Trough above MIC Increase doses for high MIC organisms and patients with high CCr When in doubt, combine antibiotics. When sure of isolates, refine regimens Gram Stain is the best monitoring tool Computer software to Estimate AUICs 15

Computerized Estimation of AUIC Selected patients who are now undertreated will benefit from the addition of a second antibiotic, or higher doses Less resistance, fewer failures, shortened therapy Most cephalosporin doses will be lowered (elderly patients, low MIC organisms) Cost Savings in the antibiotic budget 16

Use of AUIC in Patient Care 77 yom, 70 in, 155 lb, with COPD, Lung Ca, and Diabetes, 7 days post-op LLL resection. Now with new S&S of LRTI, on a Ventilator Cefazolin for prophylaxis day 1, currently receiving no ABX. Serum creatinine is 1.2 mg/dl Cx taken, Ceftazidime 1.0 gm Q12hr is ordered. You were consulted for antibiotic management 17

Calculation of AUICs DOSE 24 /Clearance=AUC 24 Clearance = CCr(x) +Clnr Adjust AUC for 24 hr of Dosing if not already done MIC as Default or Exact value? AUIC 24 =AUC 24 /MIC 18 18

The A.U.I.C. Program for Antimicrobial Dosing ANTIBIOTIC UTILIZATION INFORMATION AND CONSULTATION ANTIBIOTIC UTILIZATION INFORMATION AND CONSULTATION ANTIBIOTIC UTILIZATION INFORMATION AND CONSULTATION ANTIBIOTIC UTILIZATION INFORMATION AND CONSULTATION ANTIBIOTIC UTILIZATION INFORMATION AND CONSULTATION ANTIBIOTIC UTILIZATION INFORMATION AND CONSULTATION ANTIBIOTIC UTILIZATION INFORMATION AND CONSULTATION Version 1.0.0a Copyright 1987 93, 1997 9, 2000-2001 Jerome J Schentag and Martin H Adelman Buffalo NY Developed by: Martin Adelman, PhD and Jerome J Schentag, PharmD 19

Home Screen-Palm AUIC 20

AUIC Screening by Computer Selected patients who are now under-treated will benefit from the addition of a second antibiotic, or from the use of higher doses Less resistance, fewer failures, shortened therapy Most cephalosporin doses will be lowered (elderly patients, low MIC organisms) Cost Savings in the antibiotic budget Requires integrated computer datafiles 21

Computer Assisted Antibiotic Management Pharmacy Orders Census Admissions Financials Micro/Lab Results Clinical Database Antibiotic Management AUIC Calcs. Cycling Protocols Infection Control 22

Antibiotic Management and Infection Control Custom Reports for Specialists List of Target Organisms Antibiograms by unit or even by room, with ABX Use data Target Sites of Infection Resistance surveillance functions 23

Clinical Pharmacy Goals Implement AUIC dosing adjustment program for improvement of clinical outcomes. Raise doses for high MICs Implement regimen refinement program to lower costs after first 3 days of Intravenous therapy 24

Type of Antibiotic Interventions Regimen Changes 14% Dosage Adjustment Change to oral 17% 40% Antibiotics D/C 18% 11% CPL Protocols 25

Antibiotic Modifications By day 3 of treatment, most patients: Have improved clinically Have an Identified organism in cultures taken on day 1 Have organism eradication or inoculum reduction Are taking oral diets and/or Medications 26